Skip to the page

Data / Form D filings / GRO Biosciences Inc.

GRO Biosciences Inc.: Form D filings

GRO Biosciences Inc., a technology company in Cambridge, MA, filed 4 Form D notices with the SEC between 2017 and 2024. The latest, on July 25, 2024, reports $27.4 million sold of a $60.4 million offering to 13 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
750 Main Street, Cambridge, MA, 02139
Phone
(415) 999-7625
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1715412

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 25, 2024New notice$60,440,116$27,440,115$33,000,00113Jul 18, 2024sec.gov
Mar 22, 2019New notice$3,749,998$3,749,99810Mar 14, 2019sec.gov
Sep 21, 2017Amendment$2,099,998$2,099,9988Aug 16, 2017sec.gov
Aug 30, 2017New notice$2,099,998$2,099,9988Aug 16, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ming J FangDirector
Bruce J BeutelDirector
Dan J BeckerDirector
Tracey J LodieExecutive Officer
Kevin J BittermanDirector
Daniel J MandellExecutive Officer, Director
Rakhshita J DharDirector

Other technology companies in Massachusetts that filed recently

Every Form D from the week of Jul 22, 2024 · All recent filings in Massachusetts · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what GRO Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.